Načítá se...
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Genetic mutations or engineered nucleases that disrupt the HIV co-receptor CCR5 block HIV infection of CD4(+) T cells. These findings have motivated the engineering of CCR5-specific nucleases for application as HIV therapies. The efficacy of this approach relies on efficient biallelic disruption of...
Uloženo v:
| Vydáno v: | Sci Transl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4790757/ https://ncbi.nlm.nih.gov/pubmed/26424571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aac5530 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|